About Emtricitabine,Tenofovir Alafenamide Fumarate
Class: | Antiretroviral agent; NRTI (Nucleoside Reverse Transcriptase Inhibitor) and NtRTI (Nucleotide Reverse Transcriptase Inhibitor)
Use: | Indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg, as part of a complete regimen. It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in at-risk adults and adolescents.
Adult dose: | One tablet (Emtricitabine 200 mg / Tenofovir Alafenamide 10
Drug Class
Antiretroviral agent; NRTI (Nucleoside Reverse Transcriptase Inhibitor) and NtRTI (Nucleotide Reverse Transcriptase Inhibitor)
Uses & Indications
Indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg, as part of a complete regimen. It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in at-risk adults and adolescents.
Storage Requirements
Store at room temperature (20°C to 25°C or 68°F to 77°F) in a tightly closed container, protected from moisture and light.
Manufacturer & Packaging
Manufacturer: Gilead Sciences International Ltd., UNITED KINGDOM
Package Size
30s HDPE Bottle
Price & Supplier
Price in UAE: AED 2740.00
Dosage Information
Adult Dose
One tablet (Emtricitabine 200 mg / Tenofovir Alafenamide 10 mg) taken orally once daily, with or without food.
Pediatric Dose
Not approved for use in pediatric patients weighing less than 35 kg. For those weighing 35 kg or more, the adult dose applies.
Side Effects
Common side effects include nausea, diarrhea, headache, fatigue, abdominal pain, and weight gain. Serious side effects may include liver problems, kidney problems, and lactic acidosis.
Contraindications & Precautions
Contraindicated in patients with a known hypersensitivity to emtricitabine, tenofovir alafenamide, or any component of the formulation. Caution is advised in patients with pre-existing renal impairment.
Important Warnings
Important safety warnings include the risk of lactic acidosis, severe liver problems, and acute exacerbation of hepatitis B in patients with a history of hepatitis B virus infection upon discontinuation. Regular monitoring of renal function is recommended during treatment.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.